palmidrol has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onesti, E | 1 |
| Frasca, V | 1 |
| Ceccanti, M | 1 |
| Tartaglia, G | 1 |
| Gori, MC | 1 |
| Cambieri, C | 1 |
| Libonati, L | 1 |
| Palma, E | 1 |
| Inghilleri, M | 1 |
1 trial available for palmidrol and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.
Topics: Amides; Cannabinoid Receptor Agonists; Ethanolamines; Fatigue; Female; Follow-Up Studies; Humans; Ma | 2019 |